Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-059572)

Filing Details

Accession Number:: 0001209191-14-059572
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-24 15:18:15
Reporting Period:: 2014-09-23

Filing Date:: 2014-09-24
Accepted Time:: 2014-09-24 15:18:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1403708	Evoke Pharma Inc	EVOK	Pharmaceutical Preparations (2834)	208447886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579179	C Todd Brady	C/O Evoke Pharma, Inc. 505 Lomas Santa Fe Drive, Suite 270 Solana Beach CA 92075		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-23	4,000	$5.70	4,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $5.69 to $5.7507 per share, inclusive. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.